EP3810234A1 — Drug delivery device, method for manufacturing a drug delivery device and use of a welded connection
Assigned to Sanofi SA · Expires 2021-04-28 · 5y expired
What this patent protects
Drug delivery device, method for manufacturing a drug delivery device and use of a welded connection. A drug delivery device (220) is proposed which comprises: a housing (100) defining an interior; a reservoir (130) which is adapted to contain a drug (150) or contains a drug, the…
USPTO Abstract
Drug delivery device, method for manufacturing a drug delivery device and use of a welded connection. A drug delivery device (220) is proposed which comprises: a housing (100) defining an interior; a reservoir (130) which is adapted to contain a drug (150) or contains a drug, the reservoir being retained in the interior; and a closure part (200) which is secured relative to the housing and has to be disconnected from the housing to get access to the reservoir within the interior, wherein the closure part is secured relative to the housing by a connection, wherein the connection comprises a welded connection (250), and wherein the welded connection is formed between two join partners, i.e. a first join partner (100, 300) and a second join partner (200). Further, a method for manufacturing a drug delivery device is disclosed as is a use associated with drug delivery devices.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.